Get in touch

Valerie Darling

Board Director, Chief Revenue Officer, Chief Business Officer, Chief Commercial Officer: Public and Private Companies, Multilingual/Global


Biotechnology, MedTech, Clinical Diagnostics, Genomics, Proteomics AI, Oncology, Medical Devices (AI), Cell and Gene Therapy, Surgical and Hospital, Personalized Medicine.


Leadership, Innovative Strategy and Business Development, EBITDA/Revenue Growth, Fortune 100s and Startups, P&L Responsibility (1.4B), Building/Leading High Performance Teams, Fundraising, Sales and Marketing, Cybersecurity/Risk, Compliance, M&A/Integration, Go-to-Market, Commercialization, Product Launch, Global Expansion, Partnering, Supply Chain, Acquisitions/Exits, Hospital IDN/GPO/HMO Contracting, Establishing Culture Diversity, Equity and Inclusion, Board Governance: Audit, Nom/Gov, Compensation, CEO Succession.


Early-Stage/Start-up, Emerging Growth to Acquisition, mid/late-stage to IPO, VC and PE Funded, Private and Public Companies, Fortune 100 Global Public Companies.

Design by: